This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
TAK1 antibody
catalog :
VPA00224KT
quantity :
2 Westerns
price :
108 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot
product information
EntityType :
PrecisionAb™ Polyclonal
EntityCategory :
Antibodies
ProductCode :
VPA00224KT
Description :
TAK1 ANTIBODY WITH CONTROL LYSATE
Specificity :
TAK1
TargetSpecies :
Human
Host :
Rabbit
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
WB
ApplicationTypes :
Western Blotting
CrossReactivities :
Mouse
Quantity :
2 Westerns
QuantityValue :
2
QuantityType :
Westerns
GOAccessions :
GO:0000187, GO:0005515, GO:0000287, GO:0002726, GO:0002755, GO:0002756, GO:0005829, GO:0004709, GO:0005524, GO:0005671, GO:0007179, GO:0007250, GO:0007252, GO:0007254, GO:0008063, GO:0010008, GO:0032743, GO:0034130, GO:0034134, GO:0034138, GO:0034142, GO:0043123, GO:0043507, GO:0043966, GO:0045087, GO:0050852, GO:0050870, GO:0051092, GO:0051403
GOTerms :
activation of I-kappaB kinase/NF-kappaB cascade, activation of interleukin-2 production, activation of MAP kinase, activation of MAPK activity during sporulation, activation of NF-kappaB, activation of NF-kappaB transcription factor, activation of T cell activation, activation of T cell cytokine production, Ada Two-A containing complex, alpha-2 macroglobulin receptor-associated protein activity, ATAC complex, ATP:protein phosphotransferase (MAPKKKK-activated) activity, cMos, cRaf, GO:0002226, GO:0045308, JNK1 cascade, JNK2 cascade, JNK3 cascade, magnesium binding, MAP3K, MAPK activation, MAPK10 cascade, MAPK11 cascade, MAPK12 cascade, MAPK13 cascade, MAPK14 cascade, MAPK8 cascade, MAPK9 cascade, MAPKKK activity, MEK kinase activity, MEKK, MEKK1, MEKK2, MEKK3, Mil/Raf, mitogen-activated protein kinase kinase kinase activity, MLK-like mitogen-activated protein triple kinase activity, MLTK, MLTKa, MLTKb, MyD88-dependent TLR signaling pathway, MyD88-dependent toll-like receptor signalling pathway, MyD88-independent TLR signaling pathway, MyD88-independent toll-like receptor signalling pathway, NF-kappaB activation, nonspecific immune response, p38 cascade, p38 MAPK signaling, p38 MAPK signalling, positive regulation of IL-2 production, positive regulation of JUNK activity, positive regulation of NF-kappaB-inducing kinase activity, positive regulation of T lymphocyte activation, positive regulation of T lymphocyte cytokine production, positive regulation of T-cell activation, positive regulation of T-cell cytokine production, positive regulation of T-lymphocyte activation, positive regulation of T-lymphocyte cytokine production, protein amino acid binding, protein degradation tagging activity, protein folding chaperone, protein tagging activity, REKS, SAPK cascade, stimulation of I-kappaB kinase/NF-kappaB cascade, stimulation of interleukin-2 production, stimulation of JNK activity, stimulation of T cell activation, stimulation of T cell cytokine production, STK28, stress-activated MAPK signaling pathway, stress-activated MAPK signalling pathway, stress-activated MAPKKK cascade, stress-activated MAPKKK signaling pathway, stress-activated MAPKKK signalling pathway, stress-activated protein kinase cascade, T lymphocyte receptor signaling pathway, T lymphocyte receptor signalling pathway, T-cell receptor signaling pathway, T-cell receptor signalling pathway, TCR signaling pathway, TGFbeta receptor signaling pathway, TGF-beta receptor signaling pathway, TGFbeta receptor signalling pathway, TGF-beta receptor signalling pathway, Tl signaling pathway, Tl signalling pathway, TLR1 signaling pathway, TLR2 signaling pathway, TLR3 signaling pathway, TLR4 signaling pathway, T-lymphocyte receptor signaling pathway, T-lymphocyte receptor signalling pathway, Toll signalling pathway, toll-like receptor 1 signalling pathway, toll-like receptor 2 signalling pathway, toll-like receptor 3 signalling pathway, toll-like receptor 4 signalling pathway, transforming growth factor beta receptor signalling pathway, up regulation of I-kappaB kinase/NF-kappaB cascade, up regulation of interleukin-2 production, up regulation of JNK activity, up regulation of T cell activation, up regulation of T cell cytokine production, up-regulation of I-kappaB kinase/NF-kappaB cascade, upregulation of I-kappaB kinase/NF-kappaB cascade, up-regulation of interleukin-2 production, upregulation of interleukin-2 production, upregulation of JNK activity, up-regulation of JNK activity, upregulation of T cell activation, up-regulation of T cell activation, upregulation of T cell cytokine production, up-regulation of T cell cytokine production
UniprotAccessions :
O43318
Gene :
MAP3K7
GeneID URL :
www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=6885
EntityFormats :
Purified
UNSPSC :
12352203
ProductForm :
Purified IgG - liquid
PriceDKK :
804
PrimarySecondary :
Primary
PriceGBP :
83
PriceEUR :
108
PriceUSD :
108 USD
PriceCHF :
126
PriceSEK :
1077
PriceNOK :
1070
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.